在生物时代与不受控制的严重喘相关的因素
Hideki Yasui1, Kyohei Oishi2, Fumiya Nihashi3
1Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan; Center for Clinical Research, Hamamatsu University Hospital, Hamamatsu, Japan.
Respiratory medicine
|November 23, 2024
概括
即使使用了生物药物,严重的喘仍然无法控制. 血中中微粒细胞数量的增加和频繁的恶化是关键因素,中微粒细胞作为生物标志物显示出希望.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 尽管有生物疗法,但严重的喘影响着许多人,造成了重大的社会负担.
- 在当前的治疗环境中,识别导致无法控制的严重喘的因素至关重要.
研究的目的:
- 为了确定与生物时代无法控制的严重喘相关的因素.
- 评估高血中微粒细胞数和恶化频率在严重喘控制中的作用.
主要方法:
- 一项多中心前性研究招募了154名患有严重喘的患者.
- 使用喘控制问卷 (ACQ-5) 评估了喘控制.
- 后勤回归分析确定了与失控喘相关的因素 (ACQ-5 ≥1.5).
主要成果:
- 36.4%的患者患有无法控制的严重喘.
- 无法控制的喘与频繁的恶化 (≥2/年) 和血中中性粒细胞数量的增加有关.
- 升高的中性粒细胞与不受控制的喘有关,无论生物使用.
结论:
- 频繁的恶化和高血中微粒细胞数量是无法控制的严重喘的独立预测因素.
- 血中中性粒细胞数量升高可能成为严重喘的有价值生物标志物,即使有生物治疗.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
351
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
351
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237


